|
Journal of Lipid Research, Vol. 41, 1096-1102, July 2000
Copyright © 2000 by Lipid Research, Inc.
In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia
S. Meijssena,
M. Castro Cabezasa,
T. B. Twicklera,
H. Jansenb, and
D. W. Erkelensa
a Departments of Internal Medicine and Endocrinology, University Hospital Utrecht, 3508 GA Utrecht, The Netherlands
b Department of Clinical Chemistry and Internal Medicine, Erasmus University, Dijkzigt Hospital, Rotterdam, The Netherlands
Correspondence to:
M. Castro Cabezas
Overproduction of very low density lipoprotein (VLDL) is the major characteristic of subjects with familial combined hyperlipidemia (FCHL). As enhanced free fatty acid (FFA) flux to the liver may be one of the determinants of VLDL overproduction, we studied FFA changes and products of hepatic FFA metabolism in response to a 24-h oral fat loading test (50 g/m2) in 7 FCHL subjects and 7 matched control subjects. The response to the meal was subdivided into a postprandial (up to 8 h after ingestion of the meal) and postabsorptive period (from 8 to 24 h). Although postheparin plasma lipolytic activities were not different between both groups, the postprandial FFA area under the curve (FFA-AUC) and FFA incremental area under the curve (FFA-dAUC) were higher in FCHL subjects than in control subjects (6.05 ± 0.45 vs. 3.43 ± 0.46 and 2.60 ± 0.49 vs. 0.96 ± 0.31 mmol · h/L, respectively; P < 0.01 for each). The postprandial increase in ketone bodies was almost four times higher in FCHL patients. As ketogenesis occurs predominantly in hepatocytes, these findings suggest that during the postprandial period in FCHL an increased flux of FFA to the liver occurs, possibly because of inadequate incorporation of FFA into triglycerides (TGs) in adipocytes. In the postabsorptive period, FFA and ketone bodies significantly decreased in FCHL subjects, in contrast to control subjects, in whom both increased. These results may represent a diminished release of FFA from adipocytes by hormone-sensitive lipase (HSL) in FCHL patients. The decrease in postabsorptive FFA and ketone bodies in FCHL patients could not be explained by insulin-mediated inhibition of HSL, as both FCHL subjects and control subjects had similar postabsorptive insulin concentrations, which were below fasting concentrations.
This study provides in vivo evidence of impaired metabolism of postprandial FFA in FCHL, which may explain in part the hepatic VLDL overproduction characteristic of FCHL subjects.Meijssen, S., M. Castro Cabezas, T. B. Twickler, H. Jansen, and D. W. Erkelens. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia. J. Lipid Res. 2000. 41: 1096;1102.
Supplementary key words:
atherosclerosis, apoB overproduction, VLDL, triglycerides, ketone bodies, postprandial lipemia, acylation-stimulating protein, hormone-sensitive lipase

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. P. H. van Wijk, M. C. Cabezas, E. J. P. de Koning, T. J. Rabelink, R. van der Geest, and I. M. Hoepelman
In Vivo Evidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3575 - 3582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Castro Cabezas, C. Verseyden, S. Meijssen, H. Jansen, and D. W. Erkelens
Effects of Atorvastatin on the Clearance of Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
5972 - 5980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.C. Shoulders, E.L. Jones, and R.P. Naoumova
Genetics of familial combined hyperlipidemia and risk of coronary heart disease
Hum. Mol. Genet.,
April 1, 2004;
13(90001):
R149 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas
Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3
Am. J. Clinical Nutrition,
March 1, 2004;
79(3):
510 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia
J. Lipid Res.,
November 1, 2003;
44(11):
2100 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.J.M. Halkes, H. van Dijk, C. Verseyden, P.P.Th. de Jaegere, H.W.M Plokker, S. Meijssen, D.W. Erkelens, and M. C. Cabezas
Gender Differences in Postprandial Ketone Bodies in Normolipidemic Subjects and in Untreated Patients With Familial Combined Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2003;
23(10):
1875 - 1880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guerin, P. Egger, C. Soudant, W. Le Goff, A. van Tol, R. Dupuis, and M. J. Chapman
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state
J. Lipid Res.,
October 1, 2002;
43(10):
1652 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. H. Eurlings, C. J. H. van der Kallen, J. M. W. Geurts, P. Kouwenberg, W. D. Boeckx, and T. W. A. de Bruin
Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyperlipidemia
J. Lipid Res.,
June 1, 2002;
43(6):
930 - 935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meijssen, H. van Dijk, C. Verseyden, D.W. Erkelens, and M. C. Cabezas
Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2002;
22(5):
811 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. C. Cabezas
In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1576 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Verseyden, S. Meijssen, and M. C. Cabezas
Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
J. Lipid Res.,
February 1, 2002;
43(2):
274 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.J.M. Halkes, H. van Dijk, P.P.T. de Jaegere, H.W.M. Plokker, Y. van der Helm, D. W. Erkelens, and M. Castro Cabezas
Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2001;
21(9):
1526 - 1530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Stojiljkovic, D. Zhang, H. F. Lopes, C. G. Lee, T. L. Goodfriend, and B. M. Egan
Hemodynamic effects of lipids in humans
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2001;
280(6):
R1674 - R1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Redgrave, G. F. Watts, I. J. Martins, P. H. R. Barrett, J. C. L. Mamo, S. B. Dimmitt, and A. D. Marais
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test
J. Lipid Res.,
May 1, 2001;
42(5):
710 - 715.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|